QYResearch: In 2016, global revenue of insulin pump is nearly 1218 M USD
http://www.qyresearchglobal.com/goods-792375.html The global average price of insulin pump is in the decreasing trend, from 5256 USD/Unit in 2011 to 4936 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
http://www.qyresearchglobal.com/goods-792375.html
The global average price of insulin pump is in the decreasing trend, from 5256 USD/Unit in 2011 to 4936 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>QYResearch</strong><br />
<strong>QYResearch</strong> focus on Market Survey and Research<br />
www.qyresearch<strong>global</strong>.com
Beijing Hengzhou Bozhi <strong>In</strong>ternational <strong>In</strong>formation Consulting<br />
Web: qyresearch<strong>global</strong>.com | qyresearcheurope.com |<br />
qyresearch.com | qyresearch.com/engl<strong>is</strong>h |<br />
qyresearchjapan.com<br />
TEL: +86-13660489419, Office: +86-2086655165<br />
Media: press@qyresearch.com<br />
Marketing: sales@qyresearch.com<br />
Facebook: @<strong>QYResearch</strong>Official, Twitter: @<strong>QYResearch</strong>_<br />
Wechat Official Account: <strong>QYResearch</strong>, Weibo: 恒 州 博 智<br />
www.qyresearch<strong>global</strong>.com
<strong>QYResearch</strong><br />
An <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> a medical device used<br />
for the admin<strong>is</strong>tration <strong>of</strong> <strong>insulin</strong> in the<br />
treatment <strong>of</strong> diabetes mellitus, also known<br />
as continuous subcutaneous <strong>insulin</strong><br />
infusion therapy. The device configuration<br />
may vary depending on design. A<br />
traditional <strong>pump</strong> includes: the <strong>pump</strong><br />
(including controls, processing module,<br />
and batteries); a d<strong>is</strong>posable reservoir for<br />
<strong>insulin</strong> (inside the <strong>pump</strong>) a d<strong>is</strong>posable<br />
infusion set, including a cannula for<br />
subcutaneous insertion (under the skin)<br />
and a tubing system to interface the<br />
<strong>insulin</strong> reservoir to the cannula.<br />
www.qyresearch<strong>global</strong>.com
<strong>QYResearch</strong><br />
<strong>In</strong> the last several years, <strong>global</strong> market <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> developed smoothly, with an<br />
average growth rate <strong>of</strong> 5.2%. <strong>In</strong> <strong>2016</strong>, <strong>global</strong> <strong>revenue</strong> <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> <strong>nearly</strong> <strong>1218</strong> M <strong>USD</strong>;<br />
the actual production <strong>is</strong> about 246 K units.<br />
The <strong>global</strong> average price <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> in the decreasing trend, from 5256 <strong>USD</strong>/Unit in<br />
2011 to 4936 <strong>USD</strong>/Unit in <strong>2016</strong>. With the situation <strong>of</strong> <strong>global</strong> economy, prices will be in<br />
decreasing trend in the following five years.<br />
The classification <strong>of</strong> <strong>In</strong>sulin Pump includes normal and patch <strong>pump</strong>, and the proportion <strong>of</strong><br />
normal in <strong>2016</strong> <strong>is</strong> about 82%.<br />
<strong>In</strong>sulin <strong>pump</strong> <strong>is</strong> widely used to treat Type I diabetes and Type II diabetes. The most<br />
proportion <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> used for Type I diabetes treatment, and the consumption<br />
proportion in <strong>2016</strong> <strong>is</strong> about 81%.<br />
North America region <strong>is</strong> the largest supplier <strong>of</strong> <strong>insulin</strong> <strong>pump</strong>, with a production market<br />
share <strong>nearly</strong> 65% in <strong>2016</strong>. Europe <strong>is</strong> the second largest supplier <strong>of</strong> <strong>insulin</strong> <strong>pump</strong>, enjoying<br />
production market share <strong>nearly</strong> 19% in <strong>2016</strong>.<br />
www.qyresearch<strong>global</strong>.com
<strong>QYResearch</strong> PART 1<br />
请 输 入 你 的 标 题<br />
North America <strong>is</strong> the largest consumption<br />
place, with a consumption market share<br />
<strong>nearly</strong> 34% in <strong>2016</strong>. Following North<br />
America, Europe <strong>is</strong> the second largest<br />
consumption place with the consumption<br />
market share <strong>of</strong> 24% in <strong>2016</strong>.<br />
Market competition <strong>is</strong> intense. Medtronic,<br />
Johnson & Johnson, Roche, etc. are the<br />
leaders <strong>of</strong> the industry, and they hold key<br />
technologies and patents, with high-end<br />
customers; have been formed in the monopoly<br />
position in the industry.<br />
Full Report Link: http://www.qyresearch<strong>global</strong>.com/goods-792375.html<br />
www.qyresearch<strong>global</strong>.com